3
Published 2015
Canadian Agency for Drugs and Technologies in Health
... associated side effects including drowsiness, dizziness and dry mouth; according to the product monograph...

4
Published 2015
Canadian Agency for Drugs and Technologies in Health
... associated side effects including drowsiness, dizziness and dry mouth; according to the product monograph...

5
by Banerjee, Srabani, Butcher, Robyn
Published 2020
CADTH
... the time needed for normal tissue healing. It can impact the individual's quality of life and productivity...

6
by Richardson, Robin, Adcock, Lorna
Published 2018
CADTH
..., administration of blood product) in pre-hospital settings, and to examine clinical guidelines regarding the use...

7
by Banerjee, Srabani, Butcher, Robyn
Published 2020
CADTH
... the time needed for normal tissue healing. It can impact the individual's quality of life and productivity...

8
by Richardson, Robin, Adcock, Lorna
Published 2018
CADTH
..., administration of blood product) in pre-hospital settings, and to examine clinical guidelines regarding the use...

9
by Marchand, Dave K., Young, Calvin, Loshak, Hannah
Published 2019
CADTH
... or combination product of buprenorphine with naloxone (BUP-NAL) formulations for the treatment of OUD....

10
by Marchand, Dave K., Young, Calvin, Loshak, Hannah
Published 2019
CADTH
... or combination product of buprenorphine with naloxone (BUP-NAL) formulations for the treatment of OUD....

11
Published 2016
Canadian Agency for Drugs and Technologies in Health

12
Published 2016
Canadian Agency for Drugs and Technologies in Health

13
Published 2016
Canadian Agency for Drugs and Technologies in Health

14
Published 2016
Canadian Agency for Drugs and Technologies in Health
.... For instance, the combination product piperacillin-tazobactam is often referred to as monotherapy unless...

15
Published 2016
Canadian Agency for Drugs and Technologies in Health

16
Published 2016
Canadian Agency for Drugs and Technologies in Health
.... For instance, the combination product piperacillin-tazobactam is often referred to as monotherapy unless...

17
Published 2014
Canadian Agency for Drugs and Technologies in Health

18
Published 2014
Canadian Agency for Drugs and Technologies in Health

19
by Clark, Michelle, Featherstone, Robin
Published 2019
CADTH
.... The production of methamphetamine is dangerous and produces large volumes of toxic chemical waste. In 2006...

20
by Clark, Michelle, Featherstone, Robin
Published 2019
CADTH
.... The production of methamphetamine is dangerous and produces large volumes of toxic chemical waste. In 2006...